-
Best Stocks: LinkedIn Corporation (NYSE:LNKD), HCA Holdings (NYSE:HCA), Diana Containerships Inc. (NASDAQ:DCIX), Alliance Resource Partners LP (NASDAQ:ARLP), RXi Pharmaceuticals Corporation (NASDAQ:RXII)
LinkedIn Corporation (NYSE:LNKD) announced the pricing of $1.15 billion aggregate principal amount of convertible senior notes due 2019 (the “notes”) in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Act”). LinkedIn also granted the initial purchasers of the notes a 13-day option to…
-
Investors Are Watching : Banco Bradesco S.A. (NYSE:BBD), Galena Biopharma(NASDAQ:GALE), RXi Pharmaceuticals Corporation (NASDAQ:RXII), Resource America(NASDAQ:REXI), CLDT
Banco Bradesco SA (NYSE:BBD) declared a monthly dividend on Thursday, October 23rd,AnalystRatingsNetwork reports. Stockholders of record on Thursday, November 6th will be given a dividend of 0.0084 per share on Monday, December 8th. This represents a $0.10 dividend on an annualized basis and a yield of 0.76%. The ex-dividend date of this dividend is Tuesday,…
-
Biotech Insider Buying: Arrowhead Research Corp. (NASDAQ:ARWR), Vital Therapies(NASDAQ:VTL), Ligand Pharmaceuticals Incorporated (NASDAQ:LGND), RXi Pharmaceuticals Corporation (NASDAQ:RXII), CorMedix(NYSEMKT:CRMD)
Arrowhead Research Corp (NASDAQ:ARWR) CEO Christopher Richard Anzalone acquired 16,000 shares of Arrowhead Research Corp stock on the open market in a transaction that occurred on Wednesday, October 15th. The stock was purchased at an average cost of $6.32 per share, for a total transaction of $101,120.00. Following the completion of the purchase, the chief…
-
Biotech gainers: Anacor Pharmaceuticals Inc (NASDAQ:ANAC), RXi Pharmaceuticals Corp (NASDAQ:RXII), Trevena Inc (NASDAQ:TRVN), MediciNova, Inc. (NASDAQ:MNOV)
Anacor Pharmaceuticals (NASDAQ:ANAC) had its price objective hosited by Jefferies Group from $24.00 to $25.00 in a report released on Friday. Jefferies Group currently has a buy rating on the stock. Shares of Anacor Pharmaceuticals Inc (NASDAQ:ANAC) closed at $19.50 in last trading session. Yesterday share price of the company was traded in the range…